U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15 books (48 items)

1.
GeneReviews® [Internet].

GeneReviews® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2025.

Table of Contents

2.
Jasper's Basic Mechanisms of the Epilepsies. 5th edition.

Jasper's Basic Mechanisms of the Epilepsies. 5th edition.

Noebels JL, Avoli M, Rogawski MA, et al., editors.

New York: Oxford University Press; 2024.

Table of Contents

3.
Fidanacogene Elaparvovec (Beqvez): CADTH Reimbursement Review: Therapeutic area: Hemophilia B [Internet].

Fidanacogene Elaparvovec (Beqvez): CADTH Reimbursement Review: Therapeutic area: Hemophilia B [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jun.

Table of Contents

4.
Medical Microbiology. 4th edition.

Medical Microbiology. 4th edition.

Baron S, editor.

Galveston (TX): University of Texas Medical Branch at Galveston; 1996.

Table of Contents

5.
Holland-Frei Cancer Medicine. 6th edition.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

Table of Contents

6.
Retroviruses.

Retroviruses.

Coffin JM, Hughes SH, Varmus HE, editors.

Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997.

Table of Contents

7.
Big Data and Analytics for Infectious Disease Research, Operations, and Policy: Proceedings of a Workshop.

Big Data and Analytics for Infectious Disease Research, Operations, and Policy: Proceedings of a Workshop.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health; Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2016 Dec 8.

Table of Contents

8.
Translational Neuroscience: Toward New Therapies [Internet].

Translational Neuroscience: Toward New Therapies [Internet].

Nikolich K, Hyman SE, editors.

Cambridge (MA): MIT Press; 2015.

Table of Contents

9.
Etranacogene Dezaparvovec (Hemgenix): Therapeutic area: Hemophilia B: CADTH Reimbursement Review [Internet].

Etranacogene Dezaparvovec (Hemgenix): Therapeutic area: Hemophilia B: CADTH Reimbursement Review [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Sep.

Table of Contents

10.
Human Papillomaviruses.

Human Papillomaviruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1995. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 64.)

Table of Contents

11.
Oversight and Review of Clinical Gene Transfer Protocols: Assessing the Role of the Recombinant DNA Advisory Committee.

Oversight and Review of Clinical Gene Transfer Protocols: Assessing the Role of the Recombinant DNA Advisory Committee.

Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee; Board on Health Sciences Policy; Institute of Medicine; Lenzi RN, Altevogt BM, Gostin LO, editors.

Washington (DC): National Academies Press (US); 2014 Mar 27.

Table of Contents

12.
Biodefense in the Age of Synthetic Biology.

Biodefense in the Age of Synthetic Biology.

National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Life Sciences; Board on Chemical Sciences and Technology; Committee on Strategies for Identifying and Addressing Potential Biodefense Vulnerabilities Posed by Synthetic Biology.

Washington (DC): National Academies Press (US); 2018 Jun 19.

Table of Contents

13.
Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop.

Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders; Stroud C, Bain L, editors.

Washington (DC): National Academies Press (US); 2019 Sep 20.

Table of Contents

14.
Clinical Review Report: Onasemnogene Abeparvovec (Zolgensma): (Novartis Pharmaceuticals Canada Inc.): Indication: For the treatment of pediatric patients with 5q spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene and: 3 or fewer copies of SMN2 gene; or infantile-onset SMA [Internet].

Clinical Review Report: Onasemnogene Abeparvovec (Zolgensma): (Novartis Pharmaceuticals Canada Inc.): Indication: For the treatment of pediatric patients with 5q spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene and: 3 or fewer copies of SMN2 gene; or infantile-onset SMA [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 May.

Table of Contents

15.
Gene therapy for choroideremia using an adeno-associated viral vector encoding Rab escort protein 1: the REGENERATE open-label trial.

Gene therapy for choroideremia using an adeno-associated viral vector encoding Rab escort protein 1: the REGENERATE open-label trial.

Cehajic-Kapetanovic J, Bellini MP, Taylor LJ, et al.; REGENERATE Study Group.

Southampton (UK): National Institute for Health and Care Research; 2024 May. (Efficacy and Mechanism Evaluation, No. 11.09.)

Table of Contents

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...